Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nanopore Technologies Regulatory News (ONT)

Share Price Information for Oxford Nanopore Technologies (ONT)

Share Price is delayed by 15 minutes
Get Live Data
130.90    0.60 (0.46%)
Bid:
130.90
Ask:
133.00
Spread: 2.10 (1.604%)
Market Cap: £1.27b
ONT Live PriceLast checked at - London Stock Exchange

Intraday Oxford Nanopore Technologies Share Chart

Share Incentive Plan - Director/PDMR Shareholding

13 Feb 2023 17:00

RNS Number : 7633P
Oxford Nanopore Technologies plc
13 February 2023
 

13 February 2023

Oxford Nanopore Technologies plc (the "Company")

Share Incentive Plan ("SIP") PDMR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 13 February 2023, it made an award of Partnership Shares (as defined in the SIP) of 67 ordinary shares of £0.0001 each ("Ordinary Shares") on behalf of Tim Cowper, a director of the Company and a Person Discharging Managerial Responsibilities ("PDMR") and 67 Ordinary Shares on behalf of Clive Brown, a director of the Company and a PDMR. The Ordinary Shares were purchased using each participating employee's gross salary at a price of £2.23 per Ordinary Share.

Under the SIP, the SIP Trustee will award each participating employee one Matching Share (as defined in the SIP) for each Ordinary Share purchased by the employee under the SIP. On 13 February 2023, the Company issued 67 Ordinary Shares to the SIP Trustee to hold on behalf of Tim Cowper to satisfy the Matching Shares awarded under the SIP to him on that date, and 67 Ordinary Shares to the SIP Trustee to hold on behalf of Clive Brown to satisfy the Matching Shares awarded under the SIP to him on that date.

Further details of the transactions referred to above by the SIP Trustee are set out below:

Name of PDMR

Number of Partnership Shares

Number of Matching Shares

Tim Cowper (Director)

67

67

Clive Brown (Director)

67

67

 

This announcement is made pursuant to the Company's obligations under Article 19(3) of the UK Market Abuse Regulation.

Tim Cowper - purchase of shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Timothy Cowper

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Purchase of Ordinary Shares under the SIP, held through the SIP Trustee.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.23

67

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

67 shares

£149.41

 

e)

Date of the transaction

13 February 2023

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

Tim Cowper - issue of new shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Timothy Cowper

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Grant of Matching Shares through an issue of Ordinary Shares under the SIP, held through the SIP Trustee

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

67

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

67 shares

Nil

e)

Date of the transaction

13 February 2023

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

Clive Brown - purchase of shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Gavin Brown

2

Reason for the notification

a)

Position/status

Chief Technology Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Purchase of Ordinary Shares under the SIP, held through the SIP Trustee.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£2.23

67

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

67 shares

£149.41

e)

Date of the transaction

13 February 2023

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

Clive Brown - issue of new shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Gavin Brown

2

Reason for the notification

a)

Position/status

Chief Technology Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Grant of Matching Shares through an issue of Ordinary Shares under the SIP, held through the SIP Trustee

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

67

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

67 shares

Nil

e)

Date of the transaction

13 February 2023

f)

Place of the transaction

London Stock Exchange (XLON)

 

Enquiries:

Investors

ir@nanoporetech.com 

Media 

media@nanoporetech.com

oxfordnanoporetechnologies@tulchangroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASADFSXDEFA
Date   Source Headline
12th Mar 20244:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Mar 20247:00 amRNSOxford Nanopore to Present at Barclays Conference
8th Mar 202412:00 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSFY23 Preliminary Results
1st Mar 20242:00 pmRNSIssue of Equity and Total Voting Rights
29th Feb 20246:00 pmRNSDirectorate Change
13th Feb 20244:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
2nd Feb 20244:30 pmRNSHolding(s) in Company
1st Feb 202412:00 pmRNSIssue of Equity and Total Voting Rights
22nd Jan 20247:00 amRNSExpansion of leadership team
11th Jan 20245:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
11th Jan 20245:30 pmRNSEmployee Stock Purchase Plan - PDMR Notification
9th Jan 20247:00 amRNSFY23 trading update
3rd Jan 20247:00 amRNSPresentation at 42nd Annual J.P. Morgan Conference
19th Dec 20232:00 pmRNSAppointment of Two Non-Executive Directors
12th Dec 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
7th Dec 20234:30 pmRNSNanopore Community Meeting Technology Update
1st Dec 20235:00 pmRNSIssue of Equity and Total Voting Rights
30th Nov 20237:00 amRNSNational Australian rare disease programme
13th Nov 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
13th Nov 202312:00 pmRNSParticipation in upcoming investor conferences
7th Nov 20238:30 amRNSAdmission to Trading on the London Stock Exchange
6th Nov 20237:00 amRNSIssue of Equity
1st Nov 20234:00 pmRNSIssue of Equity and Total Voting Rights
31st Oct 20237:00 amRNSApple showcases Oxford Nanopore in M3 launch
26th Oct 20236:10 pmRNSHolding(s) in Company
24th Oct 202312:30 pmRNSHolding(s) in Company
23rd Oct 20238:30 amRNSAdmission to Trading on the London Stock Exchange
23rd Oct 20238:30 amRNSIssue of Equity and Total Voting Rights
19th Oct 20237:00 amRNSbioMérieux makes investment in Oxford Nanopore
19th Oct 20237:00 amRNSCapital Markets Day - ONT expands into clinical
19th Oct 20237:00 amRNSMayo Clinic and Oxford Nanopore collaboration
11th Oct 20233:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
6th Oct 20233:00 pmRNSBlock Listing Interim Review
2nd Oct 20234:00 pmRNSIssue of Equity and Total Voting Rights
27th Sep 20235:00 pmRNSDirector Declaration
12th Sep 20233:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Sep 20237:00 amRNSPresentation at the Morgan Stanley Conference
6th Sep 20237:00 amRNSInterim results for the 6 months ended 30 June 23
1st Sep 20233:00 pmRNSIssue of Equity and Total Voting Rights
25th Aug 202312:00 pmRNSNotice of Results and Capital Markets Day
11th Aug 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Aug 20235:30 pmRNSIssue of Equity and Total Voting Rights
17th Jul 20237:00 amRNSHalf Year Trading Update
13th Jul 20233:30 pmRNSKate Priestman appointed as Non-Executive Director
11th Jul 20235:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
3rd Jul 20233:30 pmRNSIssue of Equity and Total Voting Rights
13th Jun 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Jun 20233:30 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.